loader image
Tuesday, October 7, 2025
77.9 F
McAllen
- Advertisement -

Medical providers receive second dose of COVID-19 vaccine

Translate to Spanish or other 102 languages!

Dr. Michelle Lopez, associate program director and assistant professor of Internal Medicine at the UTRGV School of Medicine, who was the first person to receive the COVID-19 vaccine in the Rio Grande Valley back in December, today received her second dose and is among the first group of fully vaccinated people in the region. (UTRGV Photo by Paul Chouy)

Mega Doctor News

- Advertisement -

RIO GRANDE VALLEY, TEXAS – UTRGV’s Dr. Michelle Lopez, the first person to receive the COVID-19 vaccine in the Rio Grande Valley back in December, today received her second dose and is among the first group of fully vaccinated people in the region.

Lopez, associate program director and assistant professor of Internal Medicine at the UTRGV School of Medicine, said she feels she has come full circle.

“I feel like I have closed the loop on one of the chapters in my life,” she said. “And as the weeks go by, I will feel even more protected by the vaccine. I feel like a weight has been lifted off my shoulders.”

- Advertisement -

Lopez was among the university’s frontline medical personnel who were qualified to receive the first vaccine because of their heightened exposure to the virus.

Lopez says she feels more confident now in continuing her work with patients and coworkers.

“Every day was a gamble,” she said. “Now it feels less daunting interacting with my coworkers, less daunting treating my patients, knowing I’m keeping them safe, and less daunting coming home to my own family.”

Since the start of the first round of vaccine distribution, UTRGV has inoculated more than 4,400 people in those groups that qualified. And more than 2,000 this week alone will get the second of the required two shots.

- Advertisement -

“To be the first person in the RGV to receive the vaccine was a blessing,” Lopez said. “I was very emotional.”

Three other UTRGV medical providers also got the vaccine the day the Pfizer shots arrived –Dr. Brandon Cantazaro, Dr. Chelsea Chang and Dr. Arturo Suplee Rivera.

“The vaccine has brought an incredible amount of hope,” Cantazaro said. “It’s like a light at the end of the tunnel during a time when emotions are heavy from the impact of this deadly pandemic.

“Now that I’m fully vaccinated, I will continue to follow the CDC guidelines of social distancing, wearing the mask, and washing my hands frequently. I feel more confident seeing my patients, but we still need to remember we are in a second wave of the pandemic and we need to keep moving forward with caution.”

As the CDC designates additional groups to receive the vaccine, Lopez urges the community to take the vaccine.

“When you have the opportunity to get the vaccine, I encourage folks to do so,” she said. “This is the first step of being able to move on with our lives. It has been an honor to be part of history and I thank science and I thank UTRGV.

“I’ve seen so many lives lost due to this pandemic, so it is worth getting the shots. I hope folks will consider getting the vaccine when they can.”

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Unidos Contra la Diabetes to Host 2026 Mini-Symposium and Annual Dia-Beat-IT Health Fair, Nov. 5th

Unidos Contra la Diabetes (UCD) has announced that its 2026 Mini-Symposium and Annual Dia-Beat-IT Health Fair is less than a month away. Moises Arjona Jr., MS, CHWI, Collective Impact Director for UCD, reminded community partners and stakeholders of the upcoming event, encouraging participation and support.

DHR Health Breast Cancer Symposium, Oct. 11th 

To support providers in the community, the DHR Health Continuing Medical Education Department will host the Breast Cancer Symposium on Saturday, October 11, at the Edinburg Conference Center at Renaissance, located at 118 Paseo del Prado.

DHR Health Introduces Advanced PSMA-PET Imaging with Illuccix® for Prostate Cancer Care

To support early and accurate detection, DHR Health now offers Illuccix (kit for the preparation of gallium Ga 68 gozetotide injection), a prostate-specific membrane antigen (PSMA) targeted positron emission tomography (PET) imaging tracer for the detection of prostate cancer.

TMA Supports Guidelines Recommending Younger Breast Cancer Screening Age

Women should begin routine annual mammography screenings at age 40, according to guidelines by the American College of Radiology and Society of Breast Imaging (ACR/SBI). Breast cancer screening guidelines vary on the initiation age for mammograms (40 versus 45 versus 50 years of age) and screening frequency (annual versus biennial).
- Advertisement -
×